Narcolepsy: Making the Right Diagnosis

Jennifer E. Engen

In this installment of the Around the Practice custom video program, Heidi Moawad, MD; Ruth Benca, MD, PhD; and Phyllis C. Zee, MD, PhD, reviewed the diagnosis and management of narcolepsy, joined by moderator Tom Scammell, MD. Leveraging 2 hypothetical patient cases, the panelists walked through potential approaches to treatment. […]

Know the Signs and What to Do

Jennifer E. Engen

Anxiety and depression don’t affect only adults. From 2013 to 2019, 1 in 11 children ages 3 to 17 was affected by anxiety, according to the Centers for Disease Control and Prevention (CDC). The same research showed that 1 in 5 adolescents ages 12 to 17 reported experiencing a major […]

CloudMD Reports Results of Evidence Based Study Proving iCBT as Highly Effective Treatment for Depression and Anxiety

Jennifer E. Engen

Over 5,000 individuals with clinical levels of depression and comorbid anxiety who completed CloudMD’s Therapist Assisted iCBT program experienced reliable symptom improvement VANCOUVER, British Columbia and TORONTO, June 06, 2022 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare […]

Depression Symptoms Associated With Elevated Cardiovascular Risk

Jennifer E. Engen

Study data published in the Journal of Psychosomatic Research identified an increased risk for cardiovascular disease in patients with depression. The association was most significant in patients with clinically relevant depressive symptoms. Patients with controlled depression did not have elevated cardiovascular risk compared with control participants. This retrospective study enrolled […]

Mother’s depression symptoms from preconception to postpartum linked with children’s behavioral issues

Jennifer E. Engen

Children whose mothers experience rising levels of depression from the period before pregnancy until the months just after giving birth are at greater risk of developing emotional, social and academic problems during their youth, UCLA psychology researchers and colleagues report. Their recently published seven-year study, which tracked mothers and their […]

AXS-05 Results in Reduction in Major Depression Symptoms

Jennifer E. Engen

New data indicates a positive future for AXS-05 (dextromethorphan-bupropion) as a potential treatment for patients with major depressive disorder. The drug, developed by Axsome Therapeutics, is a novel, oral investigational N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity. The results from the GEMINI phase 3 clinical trial show AXS-05 showed rapid, […]

Cybervictimization Linked With Sleep Problems, Anxiety, Depressive Symptoms, Study Says

Jennifer E. Engen

A study conducted in China found that cybervictimization was associated with sleep problems, anxiety symptoms, and depressive symptoms in adolescents. A study published in the Journal of Interpersonal Violence found that adolescents who faced cybervictimization had increased risk of sleep problems, anxiety, and depression than adolescents who were not victimized. […]